Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Pullback Is a Buying Opportunity

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Pullback Is a Buying Opportunity One company’s loss is another’s gain. Rigel PharmaceuticalsTicker: NASDAQ:RIGLPrice: $1.79 New York-based Pfizer (NYSE: PFE) is the biggest pharmaceutical company in the world, so when it slashes costs and dumps drug candidates left and right, people take note. However sometimes what gets overlooked is that one […]